News and insights into the #2 pharma/medtech market - China

Greg B. Scott founded ChinaBio® in 2007 to help western life science companies achieve success in China. ChinaBio® is a consulting and advisory firm based in Shanghai that has helped over 100 U.S., European and APAC companies seeking partnerships, acquisitions, novel ... more

ALL CONTRIBUTIONS

Week In Review: BGI Genomics Plans $250 Million Shenzhen IPO
BGI Genomics, the contract sequencing and diagnostics divisions of China genomics sequencing company BGI, filed to IPO on the Shenzhen Chi-Next exchange with a proposed target of raising $250 million.
Read
Week In Review: Fosun Eyeing $4 Billion Bid For Germany's Stada Pharma
Shanghai Fosun Pharma is said to be contemplating a bid for Germany's Stada Arzneimittel, a well established generic drug company.
Read
Week In Review: OrbiMed Plans $450 Million Target For Third Asia Life Science Fund
OrbiMed filed with the SEC to raise $450 million for its third Asia-focused fund, OrbiMed Asia Partners III. The company says it considers investments in all sectors of life science.
Read
Week In Review: BioSense Signs $68 Million China Deal With Neovacs For Therapeutic Vaccine
BioSense Global, a New Jersey-Suzhou biotech, signed a $68 million option agreement with France's Neovacs for China rights to a therapeutic vaccine aimed at lupus and dermatomyositis.
Read
Week In Review: China To Add 300 Drugs To National Reimbursement Drug List
According to sources, China is getting close to announcing a revised National Reimbursement Drug List, the group of drugs covered by China's national insurance plan. 130 will be chemical drugs and the rest will be traditional Chinese medicines.
Read
Week In Review: China Investors Announce $4 Billion Of Life Science Deals
Temasek, the sovereign wealth fund of Singapore, invested $800 million in Verily Life Sciences LLC of San Francisco (see story). Verily is the former health sciences division of Google's R&D operations, now spun out into a separate company.
Read

STOCKS I FOLLOW

AXN Aoxing Pharmaceutical Company, Inc.
CRPNF China Pioneer Pharma Holdings Ltd.
CYIG CHINA YCT INTL GROUP
HCM Hutchison Chi-Med
ICLR Icon PLC
MCRPF MICROPORT SCIENTIFIC
MDCO The Medicines Company
MR Mindray Medical International Limited
NBY NovaBay Pharmaceuticals, Inc.
SCLN SciClone Pharmaceuticals, Inc.
WX WuXi PharmaTech Inc.
Load More

TWEETS

LATEST ACTIVITY

ChinaBio® Today
Week In Review: BGI Genomics Plans $250 Million Shenzhen IPO $PFE $AMGN more
ChinaBio® Today
Week In Review: Fosun Eyeing $4 Billion Bid For Germany's Stada Pharma $BGNE more
All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications